21 - 28 of 28 Results
Technologies directed to an integrated on-board charger for dual motor based electric vehicle power train are described.
Contact:
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.
Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
This invention proposes a Honeycomb-DD coupling structure that addresses the shortcomings of the conventional honeycomb coil array and gathering the advantage of DD and honeycomb designs advantages in a single design.
Wireless charging systems need to operate at high frequency, at or near resonance, to maximize power transfer distance and efficiency. High voltages appear across the inductors and capacitors. The use of discrete components reduces efficiency, increases system complexity.
There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
The invention provides on-line analysis of droplets for mass spectrometry.
ORNL has developed a revolutionary system for wirelessly transferring power to electric vehicles and energy storage systems, enabling efficient, contactless charging.